PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsactinomycetales infections
MeSH D000193 - actinomycetales infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016908:Gram-positive bacterial infections
47 Companies
13 Drugs
$
Success rate
D000193: 
Actinomycetales infections
42 Companies
4 Drugs
$
Success rate
D000196:Actinomycosis
49 Companies
14 Drugs
$
Success rate
D003354:Corynebacterium infections
0 Companies
0 Drugs
Success rate
D009164:Mycobacterium infections
51 Companies
15 Drugs
$
Success rate
D009617:Nocardia infections
44 Companies
6 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Clindamycin
Padagis
Benzoyl peroxide,
Clindamycin
Taro Pharmaceutical
Benzoyl peroxide,
Clindamycin
Glenmark Pharmaceuticals
Benzoyl peroxide,
Clindamycin
Mylan
Benzoyl peroxide
Bausch Health Companies
Adapalene,
Benzoyl peroxide,
Clindamycin,
Tretinoin
Pfizer
Clindamycin
Zydus Therapeutics
Benzoyl peroxide,
Clindamycin
Sun Pharmaceutical Industries
Clindamycin
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use